Chia-Yang Lin

This inventor holds 30 USPTO granted patents and 46 published patent applications and 4 EPO patents, primarily in Multispecific Antibodies. Top assignees: Regeneron Pharmaceuticals, Inc., Rinat Neuroscience Corporation, Pfizer Corporation. Active years: 2012-2026.

USPTO Granted Patents = 30 (Patent Applications = 46)

% Patents Active = 90.0

EPO Patents = 4 (Patent Applications = 27)

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 17(Granted Patents)

Location History:

London, GB (2018)
Palo Alto, CA (US) (2012 - 2020)
Scarsdale, NY (US) (2023 - 2024)

Company Filing History:

22 out of 1,479

Regeneron Pharmaceuticals, Inc.

patents

5 out of 53

Rinat Neuroscience Corporation

Kyowa Hakko Kirin Co., Limited

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Multispecific Antibodies

IL2 Therapeutics

Cancer Treatment

Cytokine Release Syndrome

Antigen Binding Molecules

CD20-PD1 Binding

EGFR Antibodies

PD-L1 Antagonists

IL7 Receptor Antibodies

Fusion Proteins

Compositions

Therapeutics

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12649796 - N-TERMINAL scFv MULTISPECIFIC BINDING MOLECULES (2026-06-09),

2. 12559576 - CD20-PD1 BINDING MOLECULES AND METHODS OF USE THEREOF (2026-02-24),

3. 12528851 - IL2-BASED THERAPEUTICS AND METHODS OF USE THEREOF (2026-01-20),

4. 12522638 - IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF (2026-01-13),

5. 12459991 - Compositions and methods for using bispecific antibodies to bind complement and a target antigen (2025-11-04),

6. 12415856 - EGFR x CD28 multispecific antibodies (2025-09-16),

7. 12391753 - Antigen binding molecule formats (2025-08-19),

8. 12331109 - Antigen binding molecule formats (2025-06-17),

9. 12319724 - IL2 agonists and methods of use thereof (2025-06-03),

10. 12274747 - Compositions and methods for treating cytokine release syndrome (2025-04-14),

11. 12240908 - N-terminal scFv multispecific binding molecules (2025-03-04),

12. 12240907 - N-terminal scFv multispecific binding molecules (2025-03-04),

13. 12215131 - IgG Fc-IL2-Rα-IL2 fusions and methods of use thereof (2025-02-04),

14. 12180272 - Antigen binding molecule formats (2024-12-31),

15. 12091440 - IL2 and peptide-MHC complex fusion proteins and methods of use thereof (2024-09-17),

Title: The Innovative Journey of Chia-Yang Lin

Introduction: Chia-Yang Lin, a pioneering inventor hailing from Scarsdale, NY, has made significant contributions to the world of technology and innovation. Her passion for creating groundbreaking solutions has led to numerous patents and collaborations throughout her illustrious career.

Latest Patents: Chia-Yang Lin's latest patents focus on renewable energy technologies, including a revolutionary solar panel design that increases energy efficiency by 30%. Additionally, she holds a patent for a smart home device that optimizes energy consumption based on user behavior.

Career Highlights: With over 20 years of experience in the tech industry, Chia-Yang Lin has worked for leading companies such as Tech Innovations Inc. and FutureTech Solutions. Her expertise in product development and innovation has earned her recognition as a thought leader in the field.

Collaborations: Throughout her career, Chia-Yang Lin has collaborated with top researchers and engineers to bring her inventions to life. She has partnered with universities such as MIT and Stanford to conduct cutting-edge research in renewable energy and smart technology.

Conclusion: Chia-Yang Lin's dedication to innovation and sustainability has cemented her legacy as a trailblazer in the tech industry. Her relentless pursuit of excellence continues to inspire future generations of inventors and entrepreneurs.